Ascendis Pharma A/S (Ascendis Pharma A/S) Purchase Of Business

: $0.0 Mil (TTM As of Dec. 2023)

View and export this data going back to 2015. Start your Free Trial

Ascendis Pharma A/S's purchase of business for the three months ended in Dec. 2023 was $0.0 Mil. It means Ascendis Pharma A/S spent $0.0 Mil on purchasing business. Ascendis Pharma A/S's purchase of business for the trailing twelve months (TTM) ended in Dec. 2023 was $0.0 Mil.

Compared with last quarter ($0.0 Mil in Sep. 2023 ), Ascendis Pharma A/S spent the same money on purchasing business in Dec. 2023 ($0.0 Mil).

Ascendis Pharma A/S Purchase Of Business Historical Data

The historical data trend for Ascendis Pharma A/S's Purchase Of Business can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ascendis Pharma A/S Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Purchase Of Business

-11.51

Ascendis Pharma A/S Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Purchase Of Business																-	-	-	-	-

Ascendis Pharma A/S Purchase Of Business Calculation

The amount used to purchase business.

Purchase Of Business for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.0 Mil.

Ascendis Pharma A/S Purchase Of Business Related Terms

Thank you for viewing the detailed overview of Ascendis Pharma A/S's Purchase Of Business provided by GuruFocus.com. Please click on the following links to see related term pages.

Ascendis Pharma A/S (Ascendis Pharma A/S) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ascendis Pharma A/S (NAS:ASND) » Definitions » Purchase Of Business

Comparable Companies

Traded in Other Exchanges

ASND:Mexico A71:Germany A1SN34:Brazil

Address

Tuborg Boulevard 12, Hellerup, DNK, DK-2900

Website

http://www.ascendispharma.com

Ascendis Pharma A/S is a biopharmaceutical company. It develops prodrug therapies with profiles to address large markets with unmet medical needs with its Transcon technology. The firm's product pipeline includes Transcon growth hormone, Transconpeptides, Transcon PTH, Transcon CNP, and others. It operates in North America, China, and Europe and derives the majority of its revenue from North America.